Loomis Sayles & Co. L P Grows Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)

Loomis Sayles & Co. L P grew its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 2.7% during the 4th quarter, HoldingsChannel reports. The fund owned 2,334,597 shares of the company’s stock after buying an additional 62,366 shares during the period. Loomis Sayles & Co. L P’s holdings in Doximity were worth $124,644,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently made changes to their positions in the stock. Handelsbanken Fonder AB lifted its stake in Doximity by 0.7% during the fourth quarter. Handelsbanken Fonder AB now owns 29,700 shares of the company’s stock worth $1,586,000 after purchasing an additional 200 shares during the last quarter. UMB Bank n.a. raised its holdings in shares of Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after buying an additional 235 shares in the last quarter. Fielder Capital Group LLC lifted its position in Doximity by 4.5% in the 4th quarter. Fielder Capital Group LLC now owns 5,488 shares of the company’s stock worth $293,000 after buying an additional 235 shares during the last quarter. Larson Financial Group LLC lifted its position in Doximity by 49.4% in the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock worth $40,000 after buying an additional 250 shares during the last quarter. Finally, GAMMA Investing LLC boosted its stake in Doximity by 20.6% in the fourth quarter. GAMMA Investing LLC now owns 1,735 shares of the company’s stock worth $93,000 after buying an additional 296 shares in the last quarter. 87.19% of the stock is owned by institutional investors.

Doximity Stock Down 6.9 %

Doximity stock opened at $61.52 on Thursday. Doximity, Inc. has a 52-week low of $22.96 and a 52-week high of $85.21. The company has a market cap of $11.49 billion, a P/E ratio of 61.52, a P/E/G ratio of 4.10 and a beta of 1.34. The business has a 50-day simple moving average of $65.24 and a two-hundred day simple moving average of $54.11.

Insider Transactions at Doximity

In other news, Director Timothy S. Cabral sold 20,000 shares of the business’s stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the transaction, the director now owns 6,360 shares of the company’s stock, valued at approximately $366,463.20. The trade was a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 37.40% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several research analysts have commented on DOCS shares. Bank of America boosted their price objective on shares of Doximity from $54.00 to $57.00 and gave the stock a “neutral” rating in a report on Monday, January 6th. Raymond James reiterated an “outperform” rating and issued a $83.00 target price (up previously from $65.00) on shares of Doximity in a research report on Friday, February 7th. Wells Fargo & Company restated an “equal weight” rating on shares of Doximity in a research report on Friday, February 7th. The Goldman Sachs Group raised their price objective on Doximity from $58.00 to $80.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Finally, Leerink Partners raised Doximity from a “market perform” rating to an “outperform” rating and boosted their target price for the company from $60.00 to $90.00 in a research note on Friday, February 7th. Eleven investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $64.22.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.